Will an AI-designed drug get FDA approval by the end of 2025?
Plus
31
Ṁ11502026
21%
chance
1D
1W
1M
ALL
There are currently several AI-designed drugs in clinical trials, but no AI-designed drug has received FDA approval thus far (see https://www.nature.com/articles/s41591-023-02361-0).
This market resolves to YES iff a drug where a signifcant portion of the design was carried out by non-human agents (so not a repurposed drug, but not necessarily a fully generative AI-designed drug either) gains FDA approval by EOY 2025.
This question is managed and resolved by Manifold.
Get
1,000and
3.00
Sort by:
Related questions
Related questions
Will a drug designed with significant contribution from an AlphaFold-like system pass a Phase I trial by end of 2025?
32% chance
Will FDA approve an “AI doctor” for primary care by 2025?
5% chance
Will an OpenAI model design an improved version of an existing drug in 2025?
27% chance
The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
58% chance
💊Will FDA approve 50 or more novel drugs in 2025?
76% chance
Will the US regulate AI development by end of 2025?
34% chance
Will AI developed molecules or drugs be the dominant sources of new biopharma IP by Sep 5 2029?
74% chance
Will a drug that didn't go through human clinical trials be approved by 2034?
29% chance
Will a regulatory body modeled on the FDA regulate AI in the US by the end of 2027?
16% chance
Will a drug to be used by most healthy adults be approved by 2043 year end?
70% chance